The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real life data of 601 patients from the QoliXane pancreatic cancer study.
 
Caroline Schoenherr
No Relationships to Disclose
 
Thorsten Oliver Goetze
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Celgene; Lilly; MSD; Shire
Speakers' Bureau - Lilly; MSD
 
Gerrit zur Hausen
Honoraria - Celgene
Travel, Accommodations, Expenses - Celgene; Celgene
 
Alexander Reichart
No Relationships to Disclose
 
Claudia Pauligk
No Relationships to Disclose
 
Rudolf Schlag
No Relationships to Disclose
 
Gabriele Margareta Siegler
No Relationships to Disclose
 
Steffen Doerfel
No Relationships to Disclose
 
Ali Aldaoud
No Relationships to Disclose
 
Lars Hahn
No Relationships to Disclose
 
Joerg Ernst Albert Schubert
No Relationships to Disclose
 
Mark-Oliver Zahn
No Relationships to Disclose
 
Heinz-Gert Hoeffkes
No Relationships to Disclose
 
Marcel Reiser
No Relationships to Disclose
 
Michael Koenigsmann
No Relationships to Disclose
 
Wolfgang Blau
No Relationships to Disclose
 
Jens Uhlig
No Relationships to Disclose
 
Nils Homann
No Relationships to Disclose
 
Jorg Trojan
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Lilly; Merck Serono; MSD Oncology; Roche; SERVIER
Speakers' Bureau - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
 
Salah-Eddin Al-Batran
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Lilly; Merck; Roche; SERVIER
Speakers' Bureau - Celgene; Lilly; Nordic Bioscience; Roche
Research Funding - Celgene; Hospira; Lilly; Medac; Novartis; Roche Pharma AG; Vifor Pharma